The pComb3 is a phage display plasmid originating from the M13 filamentous phage, containing f1 ori and geneIII sequence. Through the transformation of pComb3 into XLI-Blue cells, with the assistance of VCSM13 phages, phages displaying the protein of interest can be produced. This process allows for the panning and screening of positive clones.
Within the structure of the pComb3 plasmid, there are two expression cassettes. The first is the SacI/XbaI restriction sites, which are used for the cloning of light chains and the second is the XhoI/SpeI restriction sites, utilized for cloning heavy chains. Both types of chains are N-terminal tagged with a pelB leader peptide. This peptide guides the fusion proteins to the periplasmic space within Gram-negative bacteria. Here, pelB is removed and Fab is presented on the phage's entire surface. Furthermore, the M13 geneIII sequence, responsible for encoding the gene, can be removed using SpeI/NheI double enzyme digestion. This allows for the soluble expression of Fab.
Initially, the pComb3 was designed explicitly for Fab phage display purposes. However, its usage has been expanded into other domains as well, paving the way for the display of multiple different proteins of interest.
Cytotoxic T lymphocyte antigen 4 (CTLA-4) is a key negative regulator of the immune response. CTLA-4 can abrogate the initiation of T cell responses by raising the signaling threshold required for full T cell activation and can also terminate ongoing T cell responses. Nanobodies (Nbs) are single-domain antigen-binding fragments derived from camel heavy chain antibodies that are extremely attractive in cancer immunotherapy due to their small size, high specificity, and stability. In this study, CTLA-4-specific Nbs were selected from a high-quality dromedary immune library via phage display technology. These Nbs recognize unique epitopes on CTLA-4 and exhibit high binding rates when used on PHA-stimulated human T cells. Treatment of B16 melanoma-bearing C57BL/6 mice with anti-CTLA-4 Nanobody 16 (Nb16) slowed melanoma growth and prolonged mouse survival. These data suggest that anti-CTLA-4 Nb selected from a high-quality phage display library may be effective in the treatment of oncology patients.
In this study, healthy camels were immunized with human CTLA-4 protein seven times, peripheral blood lymphocytes were isolated, and the VHH gene was amplified from the lymphocyte cDNA. To construct the library, PstI and NotI sites were introduced at the 5' and 3' ends of the VHH fragment, respectively. A total of 10 µg of VHH fragment and 20 µg of linearized pComb3 vector were used for ligation. Then, the recombinant plasmid was transformed into TG1 cells through 30 times of electroporation. Calculate library size by counting colonies after serial dilutions. Its size reaches 1.85 × 108 colonies, which enables the acquisition of Nbs with high specificity and sequence diversity. 24 colonies were randomly selected for PCR analysis, and the PCR results showed that the library insertion rate was 95%. All these indicate that a high-quality immune phage display library has been successfully constructed, which provides a basis for subsequent screening of CTLA-4-specific Nb.
Figure 1. Construction of the VHH library. (Wan, Ruirong, et al. 2018)
The pComb3 is a multi-purpose and versatile research tool extensively used in the field of molecular biology and genetics.
Phage display using the pComb3 vector operates through the genetic modification of bacteriophages, which are viruses that naturally infect and replicate within bacterial cells. Modified bacteriophages or 'phages' express an inserted foreign gene on their surface, which creates a physical link between the protein product and the gene encoding it. This significant characteristic of pComb3 is applied by scientists to screen and isolate specific proteins or peptides with the desired properties in biological and medical research, including areas like disease diagnostics, vaccine development, and drug discovery.
One of the noteworthy applications of pComb3 vector is the production of monoclonal antibodies. By using this vector in the phage display technology, researchers have been successful in screening and isolating highly specific antibodies which bind to their target antigens with high affinity. This method has revolutionized the production of therapeutic antibodies, significantly contributing to the development of new medicines and treatments.
Furthermore, phage display using the pComb3 vector has also been employed to study protein-ligand interactions. It aids researcher in determining the binding affinity between a protein and its ligand. These findings are critical in drug development process as they provide insights into how potential drugs interact with their target proteins.
The use of the pComb3 vector in phage display method has also found applications in the field of vaccine development. It has been utilized to create antigenic peptide libraries, enabling the identification of peptides that can stimulate an immune response. Through this, researchers are able to develop vaccines against a wide range of pathogens including viruses and bacteria.
Customer Q&As
What is pComb3 vector?
A: pComb3 is a phagemid vector that is widely used for molecular cloning of the antibody repertoire and for the production of phage display libraries.
What are the expression cassettes of pComb3 plasmid?
A: pComb3 plasmid contains two expression cassettes: the SacI/XbaI restriction sites for cloning the light chain and the XhoI/SpeI restriction sites for cloning the heavy chain.
How to obtain phage displaying the target protein?
A: By transforming pComb3 into XLI-Blue cells, with the help of VCSM13 phage, positive clones can be generated, panned, and screened for phage displaying the protein of interest.
Ask a Question
Customer Reviews
Worked very well
I have found the pComb3 phage display plasmid to be an invaluable resource in my molecular biology lab. The convenience it confers in generating combinatorial antibody libraries makes complex experimentation significantly easier.
Very helpful
My experience with the pComb3 vector did pose some challenges, particularly in maneuvering its genomic size. However, its ability to display vast antigen libraries made it an essential plasmid in my work with antibody engineering.
United Kingdom
09/23/2023
Write a Review